Biophytis SA (BPTS) News

Biophytis SA (BPTS): $0.35

0.00 (0.29%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

F

Add BPTS to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#255 of 489

in industry

Filter BPTS News Items

BPTS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest BPTS News From Around the Web

Below are the latest news stories about BIOPHYTIS SA that investors may wish to consider to help them evaluate BPTS as an investment opportunity.

Biophytis Announces Receipt of Nasdaq Notice

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / November 17, 2023 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics that ...

Yahoo | November 17, 2023

Biophytis and Innovation Solutions Pharma Sign a Partnership Agreement to Accelerate Market Access for Sarconeos (BIO101) in Brazil

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / October 30,2023 / Biophytis SA (Nasdaq CM:BPTS)(Euronext Growth Paris:ALBPS), («Biophytis»), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing ...

Yahoo | October 30, 2023

Biophytis Receives Notice of Delisting From NASDAQ and Announces It Will Request a Hearing Before the NASDAQ Hearings Panel

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / October 27, 2023 / Biophytis SA (NASDAQCM:BPTS),(Euronext Growth Paris:ALBPS), ("Biophytis"), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing ...

Yahoo | October 27, 2023

Biophytis Releases Its Half-Yearly Accounts as of 30 June 2023 and Provides an Update on Its Operations

Start of industrial development of Sarconeos (BIO101) with a view to market access in severe forms of Covid-19 (COVA)Approvals to start the Phase 3 trial in the United States and Belgium in sarcopenia (SARA), a world first, opening up the prospect ...

Yahoo | September 27, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Pre-market stock movers are among the biggest topics worth checking out on Tuesday and we have the latest news for investors!

William White on InvestorPlace | September 26, 2023

Biophytis (BPTS) Soars 73% on Partnership With Skyepharma

Biophytis (BPTS) gains on signing a partnership with Skyepharma, for the production of regulatory batches of its lead candidate, Sarconeos (BIO101).

Yahoo | September 26, 2023

Why Is Biophytis (BPTS) Stock Up 49% Today?

Biophytis is a hot topic among traders on Monday after announcing a production agreement.

William White on InvestorPlace | September 25, 2023

Why Is MicroAlgo (MLGO) Stock Down 29% Today?

MicroAlgo stock is sliding lower on Monday after shares of MLGO underwent a rally on Friday following a new algorithm announcement.

William White on InvestorPlace | September 25, 2023

Why Is Farmmi (FAMI) Stock Down 4% Today?

Farmmi (FAMI) stock is sliding on Monday after the Chinese agricultural products company announced a reverse stock split.

William White on InvestorPlace | September 25, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time for another dive into the biggest pre-market stock movers as we check out all of the latest news on Monday morning!

William White on InvestorPlace | September 25, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!